Cross-Site Scripting Vulnerability in IBM Engineering Test Management

CVE-2021-38934

What is CVE-2021-38934?

IBM Engineering Test Management versions 7.0, 7.0.1, and 7.0.2 are susceptible to a cross-site scripting vulnerability. This issue allows attackers to inject arbitrary JavaScript code into the web interface, potentially manipulating the application's functionality and leading to unauthorized access to sensitive information, including user credentials during a trusted session. It's crucial for users to implement targeted security measures to mitigate the risk associated with this vulnerability.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch →

References